A Guide To Key Schedules In Indian Pharma And Cosmetics Regulations

Cosmetics Regulations

India’s pharmaceutical and cosmetic sectors are governed by a comprehensive regulatory framework under the Drugs and Cosmetics Act, 1940, along with associated rules. A critical component of this framework is the classification system defined through various schedules, which outline requirements for manufacturing, distribution, labeling, safety, and compliance.

For pharmaceutical manufacturers, cosmetic brands, regulatory professionals, and global exporters, understanding these schedules is essential to ensure regulatory approval, product safety, and market access in India.

This guide by Maven Regulatory Solutions provides an in-depth overview of the key schedules in Indian pharma and cosmetic regulations, along with compliance insights and emerging regulatory trends.

Overview of Regulatory Authorities in India

Key Schedules in Indian Pharma and Cosmetics Regulations

1. Schedule H – Prescription Drugs

Scope:

• Includes antibiotics, antihypertensives, and other prescription-only medicines 

Regulatory Requirements:

• Sale only with a registered medical practitioner’s prescription  
• Mandatory labeling: “Rx only” 

Purpose:

• Prevent misuse and self-medication 
• Ensure controlled drug dispensing 

2. Schedule H1 – High-Risk Prescription Drugs

Scope:

• Includes certain antibiotics, anti-TB drugs, and habit-forming medicines 

Regulatory Requirements:

• Mandatory prescription retention for 3 years 
• Maintenance of separate sales records 

Purpose:

• Strengthen pharmacovigilance 
• Prevent antimicrobial resistance and drug abuse 

3. Schedule X – Narcotic and Psychotropic Substances

Scope:

• Includes sedatives, stimulants, and controlled substances 

Regulatory Requirements:

• Special prescription format 
• Strict storage and record-keeping requirements 
• Licensing for possession and sale 

Purpose:

• Preventing drug abuse and illegal distribution 

4. Schedule G – Drugs with Cautionary Labels

Scope:

• Hormonal drugs, corticosteroids, and other high-risk therapies 

Label Requirement:

• “Caution: It is dangerous to take this preparation except under medical supervision” 

Purpose:

• Increase patient awareness and safety 

5. Schedule K – Exemptions for Certain Drugs and Cosmetics

Scope:

• Ayurvedic, Siddha, and Unani medicines 
• Veterinary drugs 
• Household remedies 

Cosmetic Relevance:

• Herbal and traditional cosmetic products may benefit from reduced regulatory burden, depending on formulation 

Purpose:

• Support traditional medicine systems while ensuring safety 

6. Schedule M & M-II – GMP Requirements

Key Requirements:

• Infrastructure and facility standards 
• Quality control systems 
• Documentation and validation 

Purpose:

• Ensure consistent product quality and safety 

7. Schedule C & C1 – Biological Products

Scope:

• Vaccines, insulin, vitamins, sera, and biological preparations 

Cosmetic Relevance:

• Advanced cosmetic formulations using biological ingredients (e.g., collagen, peptides) may fall under scrutiny 

Purpose:

• Ensure safety and efficacy of biologically derived products 

8. Schedule D – Import Exemptions

Scope:

• Certain imported drugs and cosmetic ingredients 

Examples:

• Herbal extracts like oats, ginger, plant-based actives 

Purpose:

• Facilitate import of low-risk substances 

9. Schedule E – Toxic Substances in Traditional Products

Scope:

• Substances like arsenic, mercury, and lead 

Cosmetic Relevance:

• Applicable to herbal and Ayurvedic cosmetic formulations 

Purpose:

• Preventing harmful exposure to toxic ingredients 

Compliance and Safety in the Cosmetic Industry

Why Compliance is Critical

• Consumer Safety: Prevents harmful exposure to toxic substances 
• Regulatory Approval: Ensures smooth licensing and market entry 
• Brand Credibility: Builds trust and long-term market presence 
• Global Trade: Supports export compliance with EU and US standards 

Key Cosmetic Regulatory Requirements in India

Latest Regulatory Trends in India

1. Increased Scrutiny on Herbal and Ayurvedic Cosmetics

• Growing demand for “natural” products 
• Stronger regulatory checks on ingredient safety 

2. Ban and Restriction on Harmful Ingredients

• Increased monitoring of: 
  • Parabens 
  • Sulphates 
  • Heavy metals 

3. Digitalization of Regulatory Processes

• Online licensing and approvals 
• AI-driven compliance tracking systems 

4. Global Harmonization Efforts

• Alignment with: 
  • EU Cosmetic Regulation 
  • US FDA guidelines 

Strategic Compliance Recommendations

Advanced Considerations for Industry Stakeholders

Cosmeceuticals and Borderline Products

• Products with therapeutic claims may be classified as drugs instead of cosmetics 
• Requires CDSCO approval 

E-commerce and Digital Sales Compliance

• Online cosmetic sales must comply with: 
  • Labeling rules 
  • Traceability requirements 

Supply Chain Compliance

• Vendor qualification 
• Raw material traceability 
• Quality audits 

Conclusion

The key schedules under the Drugs and Cosmetics Act, 1940 form the backbone of India’s regulatory system for pharmaceuticals and cosmetics. A clear understanding of these schedules enables companies to:

• Ensure regulatory compliance 
• Maintain product safety and quality 
• Achieve successful market entry and expansion 

As India moves toward stricter regulations and global harmonization, companies must adopt proactive compliance strategies to stay competitive and compliant.

Frequently Asked Questions 

1. What is the most important schedule for cosmetics in India?

Schedule M-II (GMP for cosmetics) and BIS standards are critical.

2. Do herbal cosmetics require CDSCO approval?

Not always, but they must comply with safety and labeling requirements.

3. What is Schedule H1 used for?

It regulates high-risk prescription drugs with strict monitoring requirements.

4. Are biological ingredients allowed in cosmetics?

Yes, but they may fall under Schedule C & C1 depending on usage.

5. What are the labeling requirements for cosmetics in India?

They must include ingredient list, expiry date, batch number, and warnings.